← Back to all trials
Recruiting
NCT05205954
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
Conditions: Cirrhosis, End Stage Liver DIsease, Liver Cirrhosis, Liver Disease Chronic
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Massachusetts General Hospital
Location: Massachusetts General Hospital Boston Massachusetts
Summary
This research study is evaluating a program that entails a healthcare at home intervention for people with advanced liver disease.
Eligibility Criteria
Inclusion Criteria:
1. Adult patients ≥ 18 years old with diagnosis of cirrhosis based on histology, radiology, and/or elastography presenting to the emergency department or inpatient general medicine service
2. Patients must have one of the following:
1. Ascites (requiring diuretics or serial large volume paracenteses)
2. Hepatic hydrothorax (requiring diuretics)
3. Hepatic encephalopathy (requiring medications)
Exclusion Criteria: All existing MGB home hospital criteria apply, with the following taking precedent for this specific condition
1. History of solid organ transplantation
2. On hemodialysis
3. MELD score \> 20
4. Score \
Source: ClinicalTrials.gov (NCT05205954). StuddyBuddy aggregates publicly available trial information.
